Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

  • End date
    Dec 27, 2022
  • participants needed
  • sponsor
    University of Pennsylvania
Updated on 27 January 2021
kidney transplant


This study is being conducted to determine safety and effectiveness of transplanting kidneys from Hepatitis C-positive donors into Hepatitis C-negative patients on the kidney transplant waitlist, who will then be treated with the appropriate direct-acting antiviral (DAA) after the single kidney transplantation.


Open-labelled pilot clinical trial of Zepatier (Grazoprevir + Elbasvir), Mavyret (Glecaprevir + Pibrentasvir), Epclusa (Sofosbuvir + Velpatasvir), or another appropriate DAA in at least 75 HCV-negative subjects with end-stage renal disease receiving a kidney transplant from a HCV-positive donor. Eligible subjects will receive a kidney transplant from a deceased-donor, and then will receive DAA treatment after kidney transplantation when infection with HCV is confirmed in these kidney transplant recipients. Treatment will be complete after 12 weeks for most subjects.

Condition Chronic renal failure, Stage 5 Chronic Kidney Disease, Chronic Kidney Disease Stage 5, CKD Stage 5, end stage renal disease, chronic renal disease, end-stage renal disease, esrd, end-stage renal failure, end stage kidney disease, end stage renal failure
Treatment Zepatier, Mavyret
Clinical Study IdentifierNCT02743897
SponsorUniversity of Pennsylvania
Last Modified on27 January 2021


Yes No Not Sure

Inclusion Criteria

Is your age between 30 yrs and 65 yrs?
Gender: Male or Female
Do you have Chronic renal failure?
Is your age between 30 yrs and 70 yrs?
Do you have any of these conditions: end stage renal failure or chronic renal disease or end-stage renal failure or end stage renal disease or CKD Stage 5 or end-stage renal disease or en...?
Is your age between 30 yrs and 70 yrs?
Do you have any of these conditions: CKD Stage 5 or Chronic renal failure or end stage kidney disease or end stage renal disease or end stage renal failure or chronic renal disease or end...?
Is your age between 30 yrs and 70 yrs?
Do you have any of these conditions: Chronic renal failure or Chronic Kidney Disease Stage 5 or Stage 5 Chronic Kidney Disease or end-stage renal disease or end-stage renal failure or esr...?
Detectable HCV RNA
Age 60 years
Study modified Kidney donor profile index (KDPI) score 0.856 - calculated as if the kidney were HCV-negative (<>)

Exclusion Criteria

Anatomical issues in the kidney allograft that raise the risk of post-transplant complications (e.g., number or length of renal arteries or veins)
Confirmed HIV positive
Confirmed HBV positive (positive Hepatitis B surface antigen and/or HBV DNA)
Known previously failed treatment for HCV using a regimen with a direct-acting antiviral (can have received interferon monotherapy and/or interferon + ribavirin combination therapy)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note